FLUDARA

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

FLUDARABINE PHOSPHATE 50 MG/VIAL

可用日期:

SANOFI - AVENTIS ISRAEL LTD

ATC代码:

L01BB05

药物剂型:

POWDER FOR SOLUTION FOR INJ/INF

给药途径:

I.V

厂商:

GENZYME EUROPE B.V., NETHERLANDS

治疗组:

FLUDARABINE

疗效迹象:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

授权日期:

2009-02-01